-
1 Comment
Invitae Corporation is currently in a long term downtrend where the price is trading 26.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.0.
Invitae Corporation's total revenue rose by 51.5% to $100M since the same quarter in the previous year.
Its net income has dropped by 213.4% to $-241M since the same quarter in the previous year.
Finally, its free cash flow fell by 127.7% to $-122M since the same quarter in the previous year.
Based on the above factors, Invitae Corporation gets an overall score of 2/5.
Sector | |
---|---|
Industry | |
ISIN | US46185L1035 |
Exchange | F |
CurrencyCode | EUR |
Beta | 1.59 |
---|---|
Market Cap | 32M |
PE Ratio | None |
Target Price | 40.44 |
Dividend Yield | None |
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. On February 13, 2024, Invitae Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IV8.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025